References and suggested readings

  1. Achten E, Boon P, Van De Kerckhove T, Caemaert J, De Reuek J, Kunnen M (1997) Value of single-voxel proton MR spectroscopy in temporal lobe epilepsy. AJNR: American Journal of Neuroradiology 18: 1131–1139.
  2. ACR (2013) ACR Manual on Contrast Media: Version 9.
  3. Bernstein MA, King KF, Zhou XJ (2004) Handbook of MRI Pulse Sequences. Elsevier Academic Press, Burlington, MA.
  4. Block T, Frahm J (2005) Spiral imaging: a critical appraisal. Journal of Magnetic Resonance Imaging 21: 657–668.
  5. CKD Work Group (2013) Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International 3 (Suppl.): 1–150.
  6. Debatin JF, McKinnon GC (eds.) (1998) Ultrafast MRI: Techniques and Applications. Springer-Verlag, Heidelberg.
  7. De Graaf RA (2007) In vivo NMR Spectroscopy: Principles and Techniques, Second edition. John Wiley & Sons, Ltd, Chichester, West Sussex, England.
  8. DeYoe EA, Bandettini P, Neitz J, Miller D, Winans P (1994) Functional magnetic resonance imaging (FMRI) of the human brain. Journal of Neuroscience Methods 54: 171–187.
  9. DIN (2008) Magnetic Resonance Equipment for Human Application – Classification Criteria for Pulse Sequences, PAS 1081. Deutsches Institut für Normung e.V.
  10. Dixon WT (1984) Simple proton spectroscopic imaging. Radiology 153: 189–194.
  11. Edelman RR, Wielopolski P, Schmitt F (1994) Echo-planar MR imaging. Radiology 192: 600–612.
  12. Finelli DA, Kaufman B (1993) Varied microcirculation of pituitary adenomas at rapid, dynamic contrast-enhanced MR imaging. Radiology 189: 205–210.
  13. Govindaraju V, Young K, Maudsley AA (2000) Proton NMR chemical shifts and coupling constants for brain metabolites. NMR in Biomedicine 13: 129–153.
  14. Guyton AC, Hall JE (1996) Textbook of Medical Physiology, 9th edition. W. B. Saunders, Philadelphia, PA.
  15. Haacke EM, Brown RW, Thompson MR, Venkatesan R (1999) Magnetic Resonance Imaging: Physical Principles and Sequence Design. Wiley-Liss, New York.
  16. Hendrick RE (ed.) (2005) Glossary of MR Terms, 5th edition. American College of Radiology, Reston, Virginia.
  17. Henkelman RM, Bronskill MJ (1987) Artifacts in magnetic resonance imaging. Reviews of Magnetic Resonance in Medicine 2: 1–126.
  18. Hetherington HP, Pan JW, Chu W-J, Mason GF, Newcomer BR (1997) Biological and clinical MRS at ultra-high field. NMR in Biomedicine 10: 360–371.
  19. Kanal E, Barkovich AJ, Bell C, et al. (2007) ACR Guidance Document for Safe MR Practices: 2007. American Journal of Roentgenology 188: 1447–1474.
  20. Kingsley PB (2006) Introduction to diffusion tensor imaging mathematics: Part I. Tensors, rotations, and eigenvectors. Concepts in Magnetic Resonance 28A: 101–122;Part II. Anisotropy, diffusion weighting factors, and gradient encoding schemes. Concepts in Magnetic Resonance 28A: 123–154;Part III. Tensor calculation, noise, simulations, and optimizations. Concepts in Magnetic Resonance 28A, 155–179.
  21. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE (2007) Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 242: 647–649.
  22. Kvistad KA, Rydland J, Vainio J, Smethurst HB, Lundgren S, Fjøsne HE, Haraldseth O (2000) Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging. Radiology August, 216(2): 545–553.
  23. Le Bihan D (ed.) (1995) Diffusion and Perfusion Magnetic Resonance Imaging: Applications to Functional MRI. Raven Press, New York.
  24. MacFall JR, Charles HC, Black RD, et al. (1996) Human lung air spaces: potential for MR imaging with hyperpolarized He-3. Radiology 200: 553–558.
  25. Marks MP, de Crespigny A, Lentz D, Enzmann DR, Albers GW, Moseley ME (1996) Acute and chronic stroke: navigated spin-echo diffusion-weighted MR imaging. Radiology 199: 403–408.
  26. Mezrich R (1995) A perspective on k-space. Radiology 195: 297–315; Radiology 199: 874–785.
  27. Mills I (ed.) (1989) Quantities, Units, and Symbols in Physical Chemistry. International Union of Pure and Applied Chemistry, Physical Chemistry Division. Blackwell, Oxford, UK.
  28. Mugler JP, III, Brookeman JR (1988) The optimum data sampling period for maximum signal-to-noise ratio in MR imaging. Reviews in Magnetic Resonance Imaging 3: 1–51.
  29. Mugler JP, III, Driehuys B, Brookeman JR, et al. (1997) MR imaging and spectroscopy using hyperpolarized 129Xe gas: preliminary human results. Magnetic Resonance in Medicine 37: 809–815.
  30. Mukherji SK (ed.) (1998) Clinical Applications of MR Spectroscopy. Wiley-Liss, New York.
  31. Nazarian S, Roguin A, Zviman MM, et al. (2006) Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 114: 1277–1284.
  32. Neil JJ (1997) Measurement of water motion (apparent diffusion) in biological systems. Concepts in Magnetic Resonance 9: 385–401.
  33. Nitz WR (1999) MR imaging: acronyms and clinical applications. European Radiology 9: 979–997.
  34. Oosterwijk H (2000) DICOM Basics. Cap Gemini Ernst & Young.
  35. Parker DL, Guilberg G (1990) Signal-to-noise efficiency in magnetic resonance imaging. Medical Physics 17: 250–257.
  36. Pinker K, Stadlbauer A, Bogner W, Gruber S, Helbich TH (2012) Molecular imaging of cancer: MR spectroscopy and beyond. European Journal of Radiology March, 81(3): 566–577. doi: 10.1016/j.ejrad.2010.04.028. Epub 2010 Jun 4.
  37. Pipe JG, Chenevert TL (1991 A progressive gradient moment nulling design technique. Magnetic Resonance in Medicine 19: 175–179.
  38. Port M, Idee J-M, Medina C, Robic C, Sabatou M, Corot C. (2008) Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. Biometals 21: 469–490.
  39. Prüssmann, KP, Weiger M, Scheidegger MB, Bösiger P (1999) SENSE: sensitivity encoding for fast MRI. Magnetic Resonance in Medicine 42: 952–962.
  40. Runge VM, Nitz WR, Schmeets SH, Schoenberg SO (2007) Clinical 3T Magnetic Resonance. Thieme Medical Publishers, New York.
  41. Salibi N, Brown MA (1998.) Clinical MR Spectroscopy: First Principles. Wiley-Liss, New York.
  42. Sandstede JJW, Lipke C, Beer M, et al. (2000) Analysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocardium on MR imaging: use in the prediction of myocardial viability. AJR 174: 1737–1740.
  43. Semelka RC (2005) Abdominal-Pelvic MRI, 2nd edition. Wiley-Liss, New York.
  44. Shellock FG (2009) The Reference Manual for Magnetic Resonance Safety. Implants and Devices 2009. Biomedical Research Publishing Company, Los Angeles, CA.
  45. Shellock FG, Crues JV (2004) MR procedures: biologic effects, safety, and patient care. Radiology 232: 635–652.
  46. Shellock FG, Spinazzi A (2008) MRI safety pdate 2008: Part 1, MRI contrast agents and nephrogenic systemic fibrosis. Am J Roentgenol 191: 1129–1139; Part 2, Screening patients for MRI. Am J Roentgenol 191: 1140–1149.
  47. Slichter CP (1996) Principles of Magnetic Resonance, 3rd edition. Springer-Verlag, Heidelberg.
  48. Sodickson DK, Manning WJ (1997) Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency arrays. Magnetic Resonance in Medicine 38: 591–603.
  49. Sodickson DK., McKenzie CA (2001) A generalized approach to parallel magnetic resonance imaging. Medical Physics 28: 1629–1643.
  50. Sommer T, Naehle CP, Yang A, et al. (2006) Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation 114: 1285–1292.
  51. Stejskal EO, Tanner JE (1965) Spin diffusion measurements: spin echoes in the Presence of a Time-Dependent Field Gradient. Journal of Chemical Physics 42, 288-292.
  52. Tannús A, Garwood M (1997) Adiabatic pulses. NMR in Biomedicine 10: 423–434.
  53. Thomsen HS (2014) ESUR Guidelines on Contrast Media, Version 9.0. European Society of Urogenital Radiology.
  54. US Food and Drug Administration. (2006) Information on Gadolinium-Containing Contrast Agents. Center for Drug Evaluation and Research. http://www.fda.gov/cder/drug/infopage/gcca/default.htm.
  55. US Government (2008) Code of Federal Regulations, Title 21, Volume 8, Subpart B, Section 892.1000, revised 2008: Magnetic resonance diagnostic device (21CFR892.1000).
  56. Vaughan JT, Snyder CJ, DelaBarre LJ, et al. (2009) Whole-body imaging at 7T: preliminary results. Magnetic Resonance in Medicine 61: 244–248.
  57. Wilke NM, Jerosh-Herold M, Zenovich A, and Arthur Stillman A (1999) Magnetic resonance first-pass myocardial perfusion imaging: clinical validation and future applications. Journal of Magnetic Resonance Imaging 10: 676–685.
  58. Wolff SD, Balaban RS (1994) Magnetization transfer imaging: practical aspects and clinical applications. Radiology 192: 593–599.
  59. Wong EC, Buxton RB, Frank LR (1998) A theoretical and experimental comparison of continuous and pulsed arterial spin labeling techniques for quantitative perfusion imaging. Magnetic Resonance in Medicine 40: 348–355.
  60. Young IR (2000) Notes on current safety issues in MRI. NMR in Biomedicine 13: 109–115.